Fennec Pharma Director Vests 5,208 Shares in Routine Transaction
FENNEC PHARMACEUTICALS INC.
Subscribe to track FENC
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Fennec Pharma Director Vests Shares
Company: FENNEC PHARMACEUTICALS INC. (FENC) Form: 4 | Filed: 2025-11-03 Significance: Low
Insider: Raykov Rosty Title: Director
Transaction: • Type: Grant (Vesting) • Shares: 5,208 • Price: $0.00 • Value: $0 • Owned After: 92,318
Key Insight: This is a routine vesting of previously awarded restricted stock, representing a negligible 0.019% of shares outstanding. It is not a new market transaction and has minimal impact.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: FENNEC PHARMACEUTICALS INC. (FENC)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A director acquired 5,208 shares through the vesting of previously granted restricted stock, a routine event with no new cash investment.
- Market Impact: The transaction is non-material and is expected to have a neutral impact on the stock.
Company Information
| Field | Value |
|---|---|
| Company | FENNEC PHARMACEUTICALS INC. |
| Ticker Symbol | FENC |
| CIK | 0001211583 |
| Industry | BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) |
Insider Information
| Field | Value |
|---|---|
| Name | Raykov Rosty |
| CIK | 0001468316 |
| Title/Position | Director |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-10-31 |
| Transaction Code | A (Award) |
| Security Type | Common shares |
| Shares Involved | 5,208 |
| Price Per Share | $0.00 |
| Total Value | $0 |
| Shares Owned After | 92,318 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $0 |
| % of Market Cap | 0.0% |
| Shares Transacted | 5,208 |
| % of Shares Outstanding | 0.019% |
| Post-Transaction Ownership | 92,318 shares (0.331% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: Fennec Pharmaceuticals has a market capitalization of approximately $230 million. The transaction value is $0, making it financially immaterial.
- Ownership Concentration: The director's post-transaction ownership of 92,318 shares represents a minor stake of approximately 0.331% of the total shares outstanding.
- Dilution Impact: The shares are part of a previously disclosed compensation plan and were already factored into the company's diluted share count. This vesting event does not introduce new dilution.
- Transaction Significance: The acquisition represents less than 0.02% of shares outstanding. Such a small, non-cash transaction is considered routine and carries low significance.
Additional Context
Transaction Notes
- Special Circumstances: The filing's footnote clarifies that these shares were released from restriction as part of awards granted in March 2023 and May 2024. This is a vesting event, not a new purchase on the open market.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.